ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling.
ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling.
复制标题
DOI:
10.1038/s41388-021-02017-8
复制
发表时间:
2021-11
期刊:
影响因子:
8
通讯作者:
von Kriegsheim A
中科院分区:
文献类型:
--
作者:
Bolado-Carrancio A;Lee M;Ewing A;Muir M;Macleod KG;Gallagher WM;Nguyen LK;Carragher NO;Semple CA;Brunton VG;Caswell PT;von Kriegsheim A
ISG15 is an ubiquitin-like modifier that is associated with reduced survival rates in breast cancer patients. The mechanism by which ISG15 achieves this however remains elusive. We demonstrate that modification of Rab GDP-Dissociation Inhibitor Beta (GDI2) by ISG15 (ISGylation) alters endocytic recycling of the EGF receptor (EGFR) in non-interferon stimulated cells using CRISPR-knock out models for ISGylation. By regulating EGFR trafficking, ISGylation enhances EGFR recycling and sustains Akt-signalling. We further show that Akt signalling positively correlates with levels of ISG15 and its E2-ligase in basal breast cancer cohorts, confirming the link between ISGylation and Akt signalling in human tumours. Persistent and enhanced Akt activation explains the more aggressive tumour behaviour observed in human breast cancers. We show that ISGylation can act as a driver of tumour progression rather than merely being a bystander.
登录
查看更多内容
影响因子:
64.5
作者:
Boelens MC;Wu TJ;Nabet BY;Xu B;Qiu Y;Yoon T;Azzam DJ;Twyman-Saint Victor C;Wiemann BZ;Ishwaran H;Ter Brugge PJ;Jonkers J;Slingerland J;Minn AJ
通讯作者:
Minn AJ
影响因子:
8
作者:
Kiessling, A.;Hogrefe, C.;Seliger, B.
通讯作者:
Seliger, B.
影响因子:
11.8
作者:
Cerikan, Berati;Shaheen, Ranad;Schiebel, Elmar
通讯作者:
Schiebel, Elmar
影响因子:
2.7
作者:
Ankney, J. Astor;Xie, Ling;Chen, Xian
通讯作者:
Chen, Xian
DOI:
10.1016/j.bbrc.2005.08.132
发表时间:
2005-10-21
影响因子:
3.1
作者:
Giannakopoulos, NV;Luo, JK;Zhang, DE
通讯作者:
Zhang, DE